A0516 – Metabolic benefits of adding metformin to androgen deprivation therapy for patients with metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Results from the STAMPEDE metformin trial - Sachdeva, A.; Gillessen, S.; Murphy, L.; El-Taji, O.; Gray, S.; Attard, G.; Jones, R.; Adler, A.; Millman, R.; Matheson, D.; Amos, C.; Murphy, C.; et al. (European urology, 2025)